Wavelet Morphologic Stability Analysis for ICD Tachyarrhythmia Discrimination
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implantable cardioverter-defibrillators (ICDs) face challenges in accurately distinguishing between high-rate polymorphic ventricular tachyarrhythmias (VT) and fibrillation (VF) from rapidly conducted atrial fibrillation (AF), leading to inappropriate shock therapies in prophylactic ICDs.
Innovation Solution
The implementation of morphologic stability analysis using wavelet transforms to differentiate between polymorphic VT/VF and monomorphic VT/SVT by examining the consistency of QRS complex morphology, employing algorithms like Two Beat Match Percent, Multiple Beat Match Percent, and Selective Wavelet Coefficient Stability Index to determine the stability of QRS complexes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If implantable cardioverter-defibrillators use conventional detection methods to identify high-rate tachyarrhythmias, then detection speed is maintained, but specificity of VF detection deteriorates due to inability to distinguish polymorphic VT/VF from rapidly conducted AF
Solution Approach 1:
The QRS complex is segmented into multiple portions (e.g., initial portion, terminal portion) and each portion is independently analyzed for morphological stability. This segmentation allows the detection algorithm to examine specific segments of the QRS complex for polymorphism without requiring analysis of the entire complex, thereby improving VF detection specificity while managing algorithmic complexity.
Solution Approach 2:
The invention introduces a new dimension of analysis by examining morphological stability across multiple QRS complexes rather than relying solely on rate-based detection. By adding the dimension of morphological consistency analysis to the traditional rate-based detection framework, the system can distinguish polymorphic VT/VF from rapidly conducted AF without significantly increasing overall system complexity.
2Reliability
If implantable cardioverter-defibrillators deliver shock therapy based on rate-based detection alone, then response time is reduced, but inappropriate shock delivery increases due to false detection of polymorphic VT/VF
Solution Approach 1:
The system performs preliminary morphological stability analysis on QRS complexes during the tachyarrhythmia episode to determine polymorphism before committing to shock therapy delivery. By conducting this preliminary analysis using stored EGM data and morphological stability calculations, the system can accurately identify polymorphic VT/VF without requiring extended real-time analysis, thus maintaining rapid response while improving reliability.
Solution Approach 2:
The invention uses stored copies of EGM data and creates morphological templates of QRS complexes for comparison. By analyzing copies of the electrical signal data and comparing morphological features against stability criteria, the system can rapidly determine polymorphism without requiring additional real-time signal acquisition, thereby minimizing time loss while improving detection accuracy.
3Ease of operation
If implantable cardioverter-defibrillators use simplified detection algorithms, then device operation is simpler, but discrimination capability between monomorphic and polymorphic tachyarrhythmias deteriorates
Solution Approach 1:
The invention applies local quality analysis by examining morphological stability specifically within defined portions of the QRS complex rather than requiring analysis of the entire waveform. By focusing computational resources on critical segments of the QRS complex where polymorphism is most evident, the system achieves accurate discrimination between monomorphic and polymorphic tachyarrhythmias while maintaining operational simplicity through targeted rather than comprehensive analysis.
Data Source
AI summary
Methods and apparatus are provided for discriminating high rate polymorphic QRS complexes from high rate monomorphic QRS complexes to increase the specificity of detection of polymorphic VT and VF employing wavelet transform signal processing of the QRS complexes are disclosed. Wavelet transforms are applied to the sampled amplitude values of a sequence of QRS complexes to develop wavelet transform coefficient (WTC) data sets. At least selected ones of the WTC data sets are processed and comparisons are made to determine a wavelet match score. A determination is made as a function of the wavelet match scores of the series of successive QRS complexes that characterizes the most recent QRS complex as more or less likely to signify polymorphic VT or VF.